Ariel Bardach

Critical Appraisal of Systematic Reviews With Costs and Cost-Effectiveness Outcomes: An ISPOR Good Practices Task Force Report

Olena Mandrik, Johan L. Severens, Ariel Bardach et al. · Value in Health · 2021 · 107 citations · Full text

Public Affairs, Health Systems, Pharmacoeconomics +16

Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina

Adolfo Rubinstein, Lisandro D. Colantonio, Ariel Bardach et al. · BMC Public Health · 2010 · 105 citations · Full text

Pharmacy, Pharmacoeconomics, Preventive Medicine +17

The health and economic burden of smoking in 12 Latin American countries and the potential effect of increasing tobacco taxes: an economic modelling study

Andrés Pichón-Rivière, Andrea Alcaraz, Alfredo Palacios et al. · The Lancet Global Health · 2020 · 80 citations · Full text

Public Health, Health Sciences, Population Health Sciences +16

Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions

Federico Augustovski, Lisandro D. Colantonio, Julieta Galante et al. · International Journal of Health Policy and Management · 2017 · 55 citations · Full text

Pharmacy, Economics, Preventive Medicine +17

Estimation and Comparison of EQ-5D Health States' Utility Weights for Pneumoccocal and Human Papillomavirus Diseases in Argentina, Chile, and the United Kingdom

Julieta Galante, Federico Augustovski, Lisandro D. Colantonio et al. · Value in Health · 2011 · 48 citations

Pharmacy, Health Sciences, Epidemiologic Methods +9